Found 6 matching trials
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer PHASE2 This is a controlled, open-label, randomized phase- II trial (1:1 randomiza...
Show More Learn More & Join Trial
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver PHASE2 FC-6 is a Phase II, multi-center clinical trial for patients with unresecta...
Show More Location
Loma Linda University Medical Center
Learn More & Join Trial
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets PHASE2 The purpose of this study is to evaluate the safety and impact on survival ...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer PHASE2 This phase II trial studies how well bevacizumab, fluorouracil, leucovorin ...
Show More Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. PHASE3 A national, multicenter, open-label, randomized phase III study. The trial ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer PHASE2 The purpose is to study the efficacy (effectiveness) of a new drug, MK-0646...
Show More Location
Multiple Locations
Learn More & Join Trial